# OnCo record securabio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/securabio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "securabio" ;
  schema:name "SecuraBio"@en ;
  schema:alternateName "Secura Bio"@en, "Secura Bio, Inc."@en ;
  schema:description "SecuraBio is a US company that owns the PI3K inhibitor duvelisib (Copiktra), acquired from Verastem in 2020, for relapsed chronic lymphocytic leukaemia and follicular lymphoma."@en ;
  schema:url <https://onco.cc/companies/securabio/>, <https://securabio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?lead=SecuraBio> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/pik3cd/> ;
  onco:drugs <https://onco.cc/drugs/duvelisib/>, <https://onco.cc/drugs/panobinostat/> ;
  onco:trials <https://onco.cc/trials/nct06522737/> .